July 11, 2017 / 4:03 AM / 11 days ago

BRIEF-Evelo Biosciences announces $50 mln series B financing

1 Min Read

July 11 (Reuters) - Evelo Biosciences:

* Evelo Biosciences announces $50 million series B financing and expansion of board and leadership team

* Proceeds will advance multiple drug candidates to clinical testing in 2018 and expand monoclonal microbial platform

* Investors in round include GV,Celgene, Mayo Clinic and Alexandria Venture Investments Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below